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We describe a case of a young man presenting with exertional dyspnea. His chest radiograph showed
hyperlucency in his left lung, and he was subsequently diagnosed to have giant bullous emphysema. An
approach to lesions of decreased attenuation on computed tomography of the chest, with a focus on
cystic lung diseases is discussed. This is followed by a literature review of the clinical presentation,
natural history, radiology and management of giant bullous emphysema. Although this is an uncommon
condition, a clinician has to be cognizant of the fact that it may mimic other common respiratory dis-
eases. This review highlights the importance of these caveats as misguided treatment options may lead
to devastating consequences.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Case report
A 37-year-old Indonesian man presented to the respiratory
clinic for exertional dyspnea that had bothered him for a year.
A diagnosis of bronchiectasis was made in 2008 by his doctors
back home, based on a history of chronic productive cough and a
compatible chest radiograph. There was no history of any severe
respiratory infection in childhood, and he had generally been in
good health all his life. He was a never smoker, and denied any
exposure to environmental tobacco smoke or biomass fuel. He
worked as an engineer, which was the only job he had ever held. He
did have any exposure to biological or industrial dusts, gases and
fumes. He led a sedentary lifestyle, and had never taken any rec-
reational drugs. Therewas no family history of respiratory illnesses.
He remained well until 2010 when he began to feel breathless
on exertion. This was not associated with chest pain, orthopnea,
paroxysmal nocturnal dyspnea or lower limb swelling. He denied
any signiﬁcant cough, hemoptysis or wheezing. He did not have
constitutional symptoms such as fever, night sweats, anorexia or
weight loss. He also did not have any skin or joint complaints. A
repeat chest radiograph at this juncture (Fig. 1) revealed increased
lucency in the upper half of the left hemithorax. This was followed
by a chest computed tomography (CT) scan that revealedtory and Critical Medicine,
cademia, 169856, Singapore.
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Ltd. This is an open access article ubronchiectatic changes in the left lower lobe with a few small cysts
and several bullae occupying almost the entire left hemithorax (Fig.
2). Extensive blood investigations including immunoglobulin
levels, connective tissue disease screen and alpha-1 antitrypsin
level were unremarkable. Spirometry showed a forced expiratory
volume in 1 s (FEV1) to forced vital capacity (FVC) ratio of 0.83, FVC
of 2.56 L (59% of predicted), and FEV1 of 2.13 L (59% or predicted).
Bronchodilator reversibility testing was not performed. Total lung
capacity (TLC) measured via nitrogen washout method and body
plethysmography showed an unsurprising discrepancy in results;
TLC measured 3.43 L (56% of predicted) and 5.33 L (88% of pre-
dicted) respectively. However, the residual volume of 2.65 L (156%
of predicted) suggested the presence of signiﬁcant air trapping,
making dynamic hyperinﬂation the most probable physiological
explanation for the patient's breathlessness. Carbon monoxide
diffusion capacity, adjusted for hemoglobin was unremarkable at
77% of predicted.
On examination, his vital signs were stable. He had a heart rate
of 70 beats per minute, and a blood pressure of 120/80. The
respiratory rate was 18 breaths per minute, with an oxygen satu-
ration of 98% on ambient air. He was of medium build and was not
distressed at rest. No clubbing was noted in his ﬁngers. Respiratory
examination revealed a centrally located trachea, and reduced
breath sounds over the left upper chest with a dull percussion note.
Bronchoscopy was grossly normal. There were no endobron-
chial lesions. Malacia was seen in the apico-posterior segment of
the left upper division, and the left lower lobe bronchopulmonary
segments appeared mildly dilated (Fig. 3). Bronchoalveolar lavage
(BAL) was performed in the left lower lobe; there was no alveolarnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. Chest radiograph e increased lucency (arrow) in left upper zone, with increased
interstitial markings in left lower zone.
Fig. 2. CT chest e large bullae in both left upper and lower lobes, with co-existing
bronchiectasis (thin arrow) and cysts (bold arrow).
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isms were negative. Cytology smears from BAL showed foamy
alveolar macrophages and scattered polymorphs. Random endo-
bronchial biopsies were taken from bronchial mucosa in the left
upper lobe, and histology yielded fragments of bronchial mucosa
with acute inﬂammation and mucosal erosions. There was no evi-
dence of granulomatous inﬂammation or malignancy.
In view of his chest CT ﬁndings, he was diagnosed to have giant
bullous emphysema (GBE).
Discussion
Our case of GBE ismade interesting by its radiological ﬁndings of
co-existing parenchymal lesions with seemingly similar
morphology, as well as the fact that the patient was a never smoker.
We will elaborate on the radiological approach we undertook to
arrive at the diagnosis, following which a succinct literature review
of GBE will be presented.
This patient's CT images demonstrated the co-existence of mul-
tiple parenchymal abnormalities comprising bronchiectasis, cysts
and bullae. In this instance, the importance of proper nomenclature
in describing such ﬁndings cannot be overemphasized. On chest CT,
lesions of decreased attenuation are described as emphysema,
honeycombing or cysts. Emphysema lacks visible walls, and often
has a centrilobular and upper lobe predisposition. In contrast,
honeycombing is characterized by thickwalled cysts 3e10mm thick
which are aligned in one ormore rows. Compared to honeycombing,
cysts have thinner walls that are usually no more than 2 mm in
thickness. Bullae are large cysts, and their walls may be formed by
septa, pleura or compressed lung tissues. The differential diagnoses
of cystic lung diseases are myriad, and include lymphangioleio-
myomatosis (LAM), langerhans cell histiocytosis (LCH), Birt-Hogg-
Dube Syndrome and lymphoid interstitial pneumonia (LIP).
The various cystic lung diseases can be differentiated from one
another by the character and distribution of pulmonary cysts. The
cysts in LAM are typically uniform and affect both lungs diffusely
while those in LCH are irregularly shaped, preferentially affect
upper lobes, and are often associated with nodules. The presence of
chylous pleural effusions and pneumothoraces will also favor the
diagnosis of LAM [1,2]. Birt-Hogg-Dube (BHD) syndrome causes
pulmonary cysts which are similar in appearance to those in LAM.However, these cysts tend to affect lung bases, and may be asso-
ciated with non-pulmonary manifestations such as renal cysts,
malignant renal tumors, and benign tumors of the hair follicles [3].
In LIP, cysts are typically found in a bronchovascular and subpleural
distribution, and are often associated with centrilobular nodules,
ground glass changes and interlobular septal thickening [4].
What is striking about the radiographic ﬁndings in this patient is
the marked asymmetrical pattern of involvement, with large bullae
preferentially affecting and almost obliterating the entire left
hemithorax. Some cysts and areas of bronchiectasis are seen in the
Fig. 3. Malacia of apico-posterior segment of left upper division (thin arrow) (left); left lower lobe bronchopulmonary segments mildly dilated (right).
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lung diseases discussed earlier. Therefore, the most likely diagnosis
is GBE.
Idiopathic GBE is a disorder characterized by bullae occupying
more than a third of the hemithorax, and mostly affects men who
are smokers [5]. It has been sporadically described in radiological
and surgical journals since the ﬁrst case report by Burke in 1937 [6].
This condition is also known by other names such as type 1 bullous
disease, primary bullous disease of the lung and vanishing lung
syndrome. Vanishing lung syndrome can be traced back to more
than 70 years ago, when Burke published “Vanishing lungs: a case
of bullous emphysema” in the journal Radiology.
The prevalence of this condition remains unknown, as only
small case series have been reported worldwide. Its cause is
obscure, but it has been observed to have a male predisposition,
and occurs mostly in smokers [7,8]. It has been postulated that
smoking upsets the balance in alveolar proteases and antiproteases,
causing a chain reaction at the cellular level that eventually leads to
destruction of alveolar walls. More recently, oxidative stress
resulting from an imbalance between oxidant and antioxidant
proteins has also been implicated [9]. It is perhaps timely to reit-
erate at this juncture the absence of cigarette smoking in our case.
There has been no conclusive evidence with regards to the devel-
opment of GBE in non-smokers. However, it may not be unrea-
sonable to assume that different triggers (congenital or acquired)
other than cigarette smoke incite the same cascade of subcellular
inﬂammatory mediators, and thus upsets the balance of proteases/
antiproteases and oxidants/antioxidants in the lung. The corollary
of this chain reaction is the same e destruction of alveolar walls
resulting in permanent and abnormal enlargement of distal air-
spaces i.e. emphysema. Supporting this hypothesis are reports of
hereditary alpha-1 antiproteases in non-smokers who present in a
fashion not dissimilar to GBE [10]. Interestingly, infrequent asso-
ciations with medical conditions (e.g. sarcoidosis and systemic
lupus erythematous), recreational drug abuse (e.g. intravenous
methylphenidate, cocaine and marijuana), and lung cancer have
also been described [11e17].
Although sporadic resolution of bullae has been infrequently
reported, with one notable case of regression after bronchodilator
treatment, the natural history of GBE appears to be a largely
progressive one [18,19]. The rate of progression is, however, highly
variable. Enlarging bullae cause symptoms by interfering with
respiratory mechanics and gas exchange. As they grow larger, they
compress on normal lung parenchyma, reduce lung compliance,
and increase work of breathing. As dead space fraction increases
with bullae formation, gas exchange is also impaired [8].
Complications of this condition include the development of
pneumothoraces, infection of existing bullae, and progression torespiratory failure [20]. It can prove to be a diagnostic challenge
when patients with undiagnosed GBE present with acute breath-
lessness to the emergency department. A chest radiograph may not
be reliable enough to differentiate a pneumothorax from a giant
bulla, especially without a previous one for comparison [21]. In
such an instance, a chest CT scan should then be considered, as
insertion of a chest drain into a bulla can lead to catastrophic
consequences such as an iatrogenic pneumothorax, hemothorax
and death.
A chest CT typically reveals numerous cysts that can vary greatly
in size, from 1 cm to bullae large enough to occupy the entire
hemithorax. It has been noted from case series that the condition
has a propensity to affect the upper lobes, and often presents with
bilateral involvement, albeit in an asymmetric fashion [8]. Para-
septal emphysema is the predominant CT ﬁnding; this then leads to
the formation of subpleural cysts and bullae [8]. Not surprisingly,
centrilobular emphysema often co-exists, given the strong associ-
ation with cigarette smoking [22]. Occasionally, CT may detect
bronchiectasis or pulmonary hypertension [22]. The detection of
nodules, thickened bulla wall, increasing bulla size, and ﬂuid ﬁlled
bulla should raise the suspicion of an underlying lung malignancy
[17].
In addition to general measures such as smoking cessation and
vaccinations, the treatment of choice in GBE is bullectomy. In a
prospective case series of 41 patients with GBE undergoing elective
bullectomy, the procedure has been shown to improve symptoms
and lung function up to 5 years, without new bullae formation or
enlargement of pre-existing bullae at the surgical site [23]. There
was no mortality difference between open thoracotomy and video-
assisted thoracoscopic surgery. Higher mortality rates and negation
of the effects of bullectomy at 5 years were found only in patients
with diffuse emphysema. If surgery is not performed, close sur-
veillance is recommended given the association with lung cancer
[24]. However, there remains no consensus on the ideal timing for
surgery, or follow up of these patients.
It is generally accepted that bullectomy be best offered electively
to markedly symptomatic patients without underlying diffuse
emphysema. The role of spirometry in guiding therapy remains
unclear. Firstly, it appears that patients with more severely
impaired preoperative FEV1 are less likely to beneﬁt from bullec-
tomy, especially if the FEV1 is less than 35% [25,26]. However, a
successful case of marked improvement in FEV1 has been reported
recently after bullectomy [27]. Secondly, GBE is not necessarily
associated with an obstructive pathology, as clearly demonstrated
by this case. This same fact also explains the limited utility of
spirometry in the follow up of this condition. As comprehensive
lung function tests are often performed in the diagnostic work up, it
must be reiterated that total lung capacity should be measured via
C.K. Tay, Y.L. Ng / Respiratory Medicine Case Reports 14 (2015) 30e33 33body plethysmography due to volume underestimation using gas
dilution methods.
As for our patient, he is being monitored closely for worsening
symptoms, with an intention for bullectomy if his condition
worsens. His symptoms have been managed adequately with
bronchodilators. A repeat spirometry performed on follow up was
largely unchanged from before. It is fortunate that his symptoms
and effort tolerance have remained largely stable on subsequent
clinic visits.References
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